OTC · Financial Statements
Bioxytran, Inc. (BIXT) Financial Statements
$0.02
OTC: BIXT
Market Cap $2.37M
Overview Financials Dividend Bioxytran, Inc. most recently reported annual revenue of $0, net profit of $-2.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-4.0M $-2.0M $-4.0M $-2.0M $-2.0M Net Profit $-4.0M $-2.0M $-4.0M $-2.0M $-2.0M EPS $-0.04 $-0.02 $-0.03 $-0.02 $-0.02 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $0 $0 $0 $0 $1.0M Total Liabilities $3.0M $4.0M $3.0M $2.0M $3.0M Cash $0 $0 $0 $0 $1.0M Borrowings $2.0M $2.0M $2.0M $1.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-2.0M $-2.0M $-1.0M $0 $-1.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $1.0M $0 $0 $0 Net Cash Flow $0 $0 $0 $0 $1.0M Free Cash Flow $-2.0M $-2.0M $-1.0M $0 $-1.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -1.27 FCF Yield -26.21% Quick Ratio 0.09 Interest Coverage -15.22 Return 1Y -73.95% Return 3Y -82.08% Return 5Y 7366.67%
Screens featuring this stock